Sudha Visvanathan

Title: Sudha Visvanathan: Innovator in Dermatological Treatments

Introduction

Sudha Visvanathan is a prominent inventor based in Ridgefield, CT (US). She has made significant contributions to the field of dermatology, particularly in the treatment of inflammatory diseases. With a total of 2 patents, her work focuses on innovative therapeutic methods that address complex medical conditions.

Latest Patents

One of her latest patents is titled "Anti-IL-36R antibodies for the treatment of pyoderma gangrenosum." This invention provides methods for treating, preventing, or ameliorating a neutrophilic dermatosis. The methods include administering a pharmaceutical composition containing an anti-interleukin-36 receptor (anti-IL-36R) antibody to patients suffering from this condition. Another significant patent is "Biomarkers useful in the treatment of IL-23A related diseases." This invention relates to biomarkers that are useful in treating IL-23 related diseases, particularly inflammatory diseases such as psoriasis. It also includes methods for utilizing these biomarkers in therapies that employ IL-23 antagonists.

Career Highlights

Sudha Visvanathan is currently associated with Boehringer Ingelheim International GmbH, where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options for patients with challenging dermatological conditions.

Collaborations

She collaborates with notable colleagues, including Patrick Baum and Oliver Kleiner, to further enhance the impact of her research and innovations.

Conclusion

Sudha Visvanathan's contributions to dermatology through her patents and collaborative efforts highlight her role as a leading inventor in the field. Her innovative approaches to treating inflammatory diseases are paving the way for new therapeutic possibilities.